American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing
Open Access
- 1 March 2001
- journal article
- guideline
- Published by Elsevier in Genetics in Medicine
- Vol. 3 (2) , 139-148
- https://doi.org/10.1097/00125817-200103000-00009
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- Non-PCR-dependent detection of the factor V leiden mutation from genomic DNA using a homogeneous invader microtiter plate assayMolecular Diagnosis, 1999
- Factor V Arg306 → Thr (factor V Cambridge) and factor V Arg306 → Gly mutations in venous thrombotic diseaseBritish Journal of Haematology, 1998
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutationBritish Journal of Haematology, 1996
- THE LUPUS ANTICOAGULANT/ANTIPHOSPHOLIPID SYNDROMEAnnual Review of Medicine, 1996
- Plasma Homocysteine Levels in Patients With Deep Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VThe Lancet, 1994
- The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsBlood Coagulation & Fibrinolysis, 1994